• 생약학회지
• /
• 제13권3호
• /
• pp.99-101
• /
• 1982

The methanolic extracts of thirty-one medicinal plants were screened for anticholinergic and oxytocic activity in rat's ileum and uterus, respectively. In addition, their effects on the ileum and antagonism against oxytocin in the uterus were observed.

• Journal of Yeungnam Medical Science
• /
• 제24권2호
• /
• pp.305-310
• /
• 2007

수술 후 인후 합병증은 통증이나 구토에 비하면 사소한 합병증이지만 흔히 환자들이 불편을 호소한다. 양 측 내시경적 부비동 수술 후에 양 코를 막아 입으로 숨 쉬게 되어 구강 건조가 더 심할 것으로 보고 환자들을 glycopyrrolate를 전투약 하고 반전시에 쓴 경우, 전투약 하지 않고 반전에만 쓴 경우, 전투약에만 쓰고 반전은 atropine을 쓴 경우, 전투약 하지 않고 반전은 atropine으로 한 경우의 네 군으로 나누었다. 마취 종료 1시간, 6시간, 12시간, 24시간, 48시간 후의 인후통과 쉰 소리 여부를 묻고, 없는 경우 0, 있는 경우에는 감기 시 목 아픈 것 보다 약하면 1, 비슷하면 2, 더 심하면 3으로 하여 심각도를 나누어 물었다. 각 군 간의 인후통 발생률은 1군에서 조금 높았으나 유의한 차이가 없었다. 심각도는 모두 1이하로 낮았다. 쉰 소리는 모든 환자에서 발생하지 않았다. 양측 내시경적 부비동 수술 후 인후 합병증은 심각도가 낮고 24시간 내에 사라지는 것으로 항콜린성 제제 사용을 피해야 할 필요성은 없을 것으로 보인다.

• 한국임상약학회지
• /
• 제30권2호
• /
• pp.113-119
• /
• 2020

Background: Reducing the total anticholinergic burden (AB) in older adults is recommended owing to the several peripheral and central adverse effects. This study aimed to identify the AB status of patients admitted to geriatric centers for assessing the influence of the pharmacist-involved multidisciplinary geriatric team care on reducing the AB. Methods: We retrospectively reviewed the medical records of 328 older patients hospitalized in geriatric centers from July 1, 2018 to June 30, 2019, who received comprehensive geriatric assessment and pharmaceutical interventions from a multidisciplinary geriatric team. We measured the total AB scores for the medications at the time of admission and upon hospital discharge using the Korean Anticholinergic Burden Scale (KABS). The pre-admission factors associated with high AB (KABS score ≥3) at the time of admission were identified. Results: The proportion of patients with high AB significantly decreased from 41.8% (136/328) at the time of admission to 25.0% (82/328) on discharge (p<0.001). The pre-admission AB of patients transferred from skilled nursing facilities (odds ratio[OR]: 2.85, 95% CI: 1.26-3.75), taking more than 10 medications (OR: 3.70, 95% CI: 1.55-8.82), suffering from delirium (OR: 2.80, 95% CI: 1.04-7.50), or depression (OR: 2.78, 95% CI: 1.04-7.41) were significantly high. Antipsychotics were the most frequent classes of drugs that contributed to the total KABS score at the time of admission, followed by antihistamines. Conclusions: This study demonstrated that the multidisciplinary teams for geriatric care are effective at reducing AB in older adults. The factors associated with high AB should be considered when targeting pharmaceutical care in geriatric individuals.

• 약학회지
• /
• 제25권1호
• /
• pp.27-35
• /
• 1981

Etomidoline is a new synthetic atropine-like drug. The present investigation aimed to study the combined effects of etomidoline and neofopam hydrochloride which has an analgesic and muscle relaxant activity, compared with the effects of each drugs. Acute toxicities (ID$_{50}$) in mouse were 132mg/Kg (p.o.) and 49mg/Kg (i.p.) when combination ratio of etomidoline and neofopam was 1:5 and 103 mg/Kg (p.o.) and 30mg/Kg (i.p.) with the ratio of 1:10. Etomidoline showed more potent anticholinergic effects than neofopam in the isolated rat intestine. Whereas, antibarium effects were twice as active with neofopam than with etomidoline. When etomidoline and neofopam were added in combination ratio of 1 : 5, papaverine-like avtivity was increased, but no changes of anticholinergic effect were observed. Analgesic effect was measured by the anti-writhing method of Whittle in mice. Both of the concurrent and single administration of etomidoline and nefopam reduced significantly the writhing number and the effect of the concurrent administration was more active than that of single, and 1 : 5 combination was slightly more potent than 1:10. Each drug or the combined drug was administered to mice and observed the change of the pupil size. Pupil sizes were increased with each drug and with combined drug, although there were no significant differences between the each group of drugs. However, those effects were less than that of atropine sulfate.e.

• Journal of Chest Surgery
• /
• 제36권4호
• /
• pp.300-301
• /
• 2003

평소에 식이성 다한증으로 일상생활에 불편함을 호소하던 두 환자들에서 항콜리너직 약제인 benztropine을 사용하여 발한감소 효과를 보았다. 저자들은 이를 치험 하였기에 보고하는 바이다.

• 한국임상약학회지
• /
• 제11권2호
• /
• pp.89-96
• /
• 2001

Ziprasidone is equally effective as haloperidol in treating schizophrenia with fewer side effects and drug interactions. Ziprasidone is an atypical antipsychotic agent and works by blocking serotonin and dopamine receptors in the central nervous system, specifically 5-HT2A and D2 receptors. Low anticholinergic side-effects and low EPS would recommend the drug for use in the elderly. Ziprasidone inhibits reuptake of norepinephrine and serotonin at neurojunction sites in vitro, indicating a potential efficacy for depression and negative symptoms which often follow after exacerbation of schizophrenia. Patients with recent acute myocardial infarction and uncompensated heart failure are contraindicated to the drug due to a possibility of QT prolongation. Although ziprasidone is metabolized by cytochrome P450 3A4, there is no significant drug interaction with the drugs that induce or inhibit the isoenzyme. Ziprasidone is safe with coadministration of lithium and there has been no significant drug interaction reported with oral birth control pills.

• 대한후두음성언어의학회지
• /
• 제21권1호
• /
• pp.57-60
• /
• 2010

Spasmodic dysphonia is a focal dystonia of the larynx and breathy voice is a typical sign of abductor spasmodic dysphonia. A group of patients with abductor spasmodic dysphonia have a number of acoustic characteristics including abnormal fundamental frequency fluctuations and abnormally long word duration. We report a abductor spasmodic dysphonia case have enlongated voice onset time voiceless consonants and breathy voice in wide band spectrogram. The patient have the acoustic characteristics only in telephone speaking at work time. We treated the patient with anticholinergic and anticonvulsant drug and supplementary voice therapy. The breathy voice and enlongated VOT were disappeared after those treatment.

• The Korean Journal of Pain
• /
• 제8권2호
• /
• pp.357-362
• /
• 1995

Percutaneous/intrathecal chemical neurolysis of sacral nerve with 12% phenol was performed on 13 cases of hyperreflexic bladder to augment bladder capacity and to reduce bladder pressure. Urodynamic evaluations were done before and after chemical neurolysis. Mean bladder capacity increased significantly after chemical neurolysis (from 171.4 ml to 375 ml). No significant changes in bowel or injection sites were noted. The result suggests that the chemolysis of sacral nerve was available modality for hyperreflexic bladder patients, who did not respond to anticholinergic medication, before decide the more aggressive alternatives such as augmentation cystoplasty or urinary diversion.

• 대한임상독성학회지
• /
• 제7권1호
• /
• pp.23-25
• /
• 2009

A 21-year-old woman ingested 1,250 mg of diphenhydramine in a single overdose. Diphenhydramine, a rare ingredient in over-the-counter medication, is used to treat insomnia in Korea. Toxicity is usually limited to anticholinergic symptoms. The standard approach to therapy for the treatment of diphenhydramine overdose is supportive care, including physostigmines and sodium bicarbonates. Here, we review the literature and for the first time report a case of acute diphenhydramine overdosage in Korea, complicated with seizures.

• Childhood Kidney Diseases
• /
• 제7권2호
• /
• pp.174-180
• /
• 2003

목적 : 불안정 방광은 소아에서 원발성 방광 요관역류를 생성하고 지속시키는 원인으로 알려져 있다. 따라서 불안정 방광의 치료제인 항콜린제의 사용은 일차성 방광요관역류의 자연 소실율을 증가시킬 수 있으나 논쟁의 여지가 있어왔다. 저자들은 항콜린제인 옥시부티닌이 소변 가리기 훈련과 배뇨 증상이 각기 다른 소아에서 원발성 방광요관역류의 소실에 미치는 영향을 조사하고자 하였다. 방법 : 1996년 10월부터 2002년 4월까지 이화의대 목동병원에 요로 감염으로 입원한 후 방광요관역류가 발견되고 1년 후 추적 검사에서도 소실되지 않은 152명을 대상으로 하였다. 옥시부티닌군(59명)은 옥시부티닌과 trimethoprim-sulfamethoxazole을, 대조군(93명)은 trimethoprim-sulfamethoxazole만을 투약했다. 방광요관역류의 소실율을 나이, 소변 가리기 및 배뇨 장애 유무에 따라 구분하여 분석하였다. 통계 분석은 Chisquare test를 이용하였고 P-값이 0.05 미만을 유의한 것으로 간주하였다. 결과 : 방광요관역류의 변화는 옥시부티닌군(59명)에서 소실 49.2%, 호전 20.3%, 무변화 30.5%로 대조군(93명)의 45.2%, 16.1%, 38.7%와 비교해 유의한 차이는 없었다. 소변을 가리지 못하는 영유아에서 방광요관역류의 변화는 옥시부티닌군(34명)에서 소실 50.0%, 호전 23.5%, 무변화 26.5%로 대조군(52명)의 44.2%, 19.2%, 36.6%와 비교해 유의한 차이는 없었다. 소변을 가리는 소아에서 방광요관역류의 변화는 옥시부티닌군(25명)에서는 소실 48.0%, 호전 16.0%, 무변화 36.0%로 대조군(41명)의 46.3%, 12.2%, 41.5%와 비교해 유의한 차이는 없었다. 소변을 가리고 배뇨 장애도 없는 연장아에서 방광요관역류의 변화는 옥시부티닌군(9명)에서 소실 33.3%, 호전11.1%, 무변화 55.6%로 대조군(28명)의 53.6%, 10.7%, 35.7%와 비교해 유의한 차이는 없었다. 소변을 가리나 배뇨 장애를 보이는 연장아에서 방광요관역류의 변화는 옥시부티닌군(16명)에서는 소실 56.3%, 호전 18.7%, 무변화 25.0%로 대조군(13명)의 30.7%, 15.4%, 53.9%와 비교해 소실되는 경향이나 유의한 차이는 없었다. 결론 : 옥시부티닌은 소변 가리기나 배뇨 장애와 관계없이 모든 소아에서 역류의 소실율에 미치는 치료 효과가 없었다. 배뇨 장애를 보이는 연장아에서는 역류의 소실율이 약간 증가되는 경향이 있었으나 유의하지 않았다. 원발성 방광요관역류에서 옥시부티닌은 배뇨 장애를 보이는 일부 연장아에서 신중하게 사용되어져야 할 것으로 생각된다.